OA4‐AM23‐SN‐19 | Transfusion‐Transmitted Babesiosis Reported to Food and Drug Administration Before and after Implementation of the Final Guidance, 2017–2022

TransfusionVolume 63, Issue S5 p. 16A-16A SUPPLEMENT ARTICLE OA4-AM23-SN-19 | Transfusion-Transmitted Babesiosis Reported to Food and Drug Administration Before and after Implementation of the Final Guidance, 2017–2022 A. Eder, A. Eder Office of Blood Research and Review, CBER, FDASearch for more papers by this authorS. O'Callaghan, S. O'Callaghan Office of Compliance and Biologics Quality, CBER, FDASearch for more papers by this authorS. Kumar, S. Kumar Office of Blood Research and Review, CBER, FDASearch for more papers by this author A. Eder, A. Eder Office of Blood Research and Review, CBER, FDASearch for more papers by this authorS. O'Callaghan, S. O'Callaghan Office of Compliance and Biologics Quality, CBER, FDASearch for more papers by this authorS. Kumar, S. Kumar Office of Blood Research and Review, CBER, FDASearch for more papers by this author First published: 12 October 2023 https://doi.org/10.1111/trf.8_17554Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume63, IssueS5October 2023Pages 16A-16A RelatedInformation